Review Article | | Peer-Reviewed

Body Kines and Organ Crosstalks: A Mini Review

Received: 9 April 2025     Accepted: 29 April 2025     Published: 29 May 2025
Views:       Downloads:
Abstract

Multiple organs are recently being recognized as having endocrine functions through their release of different hormones and proteins that are responsible for biologically interrelated and inter-connected signaling processes. Diabetes and other chronic diseases are subject to be influenced by these products where modulation or change of their function could take place due to alterations in the signaling processes affected by the secretion of these products In this mini review we tried to take a closer look at how these proteins referred to as “kines” which are considered as the leaders of communication will help the crosstalk between different tissues and it is of utmost important to discover in what way they can do that,. We will review the multiple and complex ways by which kines affect the physiological and pathological processes through reviewing what had been published of the works dealing with the action of different kines and what are the main organs that produce them although a great number of them had not yet been discovered or studied exclusively. The deep identification of their roles in health and diseases will pave the way for the pharmaceutical industry to innovate new drugs that will target their action towards a better organ harmony for the benefits of the patients.

Published in International Journal of Diabetes and Endocrinology (Volume 10, Issue 2)
DOI 10.11648/j.ijde.20251002.13
Page(s) 45-53
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Kines, Myokines, Adiponectin, Osteocalcine, Hepatokines, Insulin Resistance

References
[1] K A Platt, H Y Min, and S R Ross. Obesity-linked regulation of the adipsin gene promoter in transgenic mice Proc Natl Acad Sci U S A. 1989 Oct; 86(19): 7490–7494.
[2] Cook KS, Min HY, Johnson D, et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science. 1987; 237(4813): 402-405.
[3] Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505): 425-432.
[4] Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006; 55(6): 1537-1545.231.
[5] Funcke JB, Scherer PE. Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication. J Lipid Res. 2019; 60(10): 1648-1684.
[6] Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund Pedersen B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000; 529(Pt 1): 237-242.
[7] Pedersen BK, Steensberg A, Fischer C, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil. 2003; 24(2-3): 113-119.
[8] Grueter CE, van Rooij E, Johnson BA, DeLeon SM, Sutherland LB, Qi X, Gautron L, Elmquist JK, Bassel-Duby R, Olson EN. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell. 2012; 149: 671–683. [PubMed: 22541436].
[9] Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130: 456–469. [PubMed: 17693256].
[10] Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100: 197–207. [PubMed: 10660043].
[11] Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005; 434: 514–520. [PubMed: 15724149].
[12] Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002; 111: 305–317. [PubMed: 12419242].
[13] Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, Confavreux C, Klemenhagen KC, Tanaka KF, Gingrich JA, Guo XE, et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell. 2009; 138: 976–989. [PubMed: 19737523].
[14] Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World J Diabetes 2015; 6(18): 1345-1354 [PMID: 26722618]
[15] Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-52.
[16] Pi M, Nishimoto SK, Darryl Quarles L. Explaining divergent observations regarding osteocalcin/GPRC6A endocrine signaling. Endocrinology 2021; 162: bqab011.
[17] Novotny SA, Warren GL, Hamrick MW. Aging and the muscle-bone relationship. Physiology (Bethesda) 2015; 30: 8-16.
[18] Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galan-Diez M, et al. Cell Metab 2016; 23: 1078-92.
[19] Jakub Krzysztof Nowicki, Elżbieta Jakubowska-Pietkiewicz. Osteocalcin: Beyond Bones. Endocrinol Metab 2024; 39: 399-406,
[20] Karsenty G, Mera P. Molecular bases of the crosstalk between bone and muscle. Bone 2018; 115: 43-9.
[21] Mera P, Laue K, Wei J, Berger JM, Karsenty G. Osteocalcin is necessary and sufficient to maintain muscle mass in older mice. Mol Metab 2016; 5: 1042-7.
[22] Oury F, Khrimian L, Denny CA, Gardin A, Chamouni A, Goeden N, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 2013; 155: 228-41.
[23] Bilezikian JP, Martin TJ, Clemens TL, Rosen CJ. Principles of bone biology. 4th ed. London: Academic Press; 2020. Chapter 20, Phosphorus homeostasis and related disorders; p. 469-507.
[24] Ho BB, Bergwitz C. FGF23, signalling and physiology. J Mol Endocrinol 2021; 66: R23-32.
[25] Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest. 2004 Feb; 113(4): 561-8.
[26] Fukumoto S. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment. J Mol Endocrinol 2021; 66: R57-65.
[27] Mai Charlotte Krogh Severinsen1 and Bente Klarlund Pedersen. Muscle–Organ Crosstalk: Th Emerging Roles of Myokines. Endocrine Reviews 41: 594 – 609, 2020.
[28] McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628): 83-90.).
[29] Kanzleiter T, Rath M, Görgens SW, et al. The myokine decorin is regulated by contraction and involved in muscle hypertrophy. Biochem Biophys Res Commun. 2014; 450(2): 1089-1094.
[30] Saremi A, Gharakhanloo R, Sharghi S, Gharaati MR, Larijani B, Omidfar K. Effects of oral creatine and resistance training on serum myostatin and GASP-1. Mol Cell Endocrinol. 2010; 317(1-2): 25-30.
[31] Hittel DS, Axelson M, Sarna N, Shearer J, Huffman KM, Kraus WE. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc. 2010; 42(11): 2023-2029.
[32] Nielsen AR, Mounier R, Plomgaard P, et al. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fiber type composition. J Physiol. 2007; 584(Pt 1): 305-312.54.
[33] Haugen F, Norheim F, Lian H, et al. IL-7 is expressed and secreted by human skeletal muscle cells. Am J Physiol Cell Physiol. 2010; 298(4): C807-C816.
[34] Bialek P, Parkington J, Li X, et al. A myostatin and activin decoy receptor enhances bone formation in mice. Bone. 2014; 60: 162-171. 162.
[35] Dankbar B, Fennen M, Brunert D, et al. Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice. Nat Med. 2015; 21 (9): 1085-1090.
[36] Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes. 2004; 53(7): 1643-1648.
[37] Lang Lehrskov L, Lyngbaek MP, Soederlund L, et al. Interleukin-6 delays gastric emptying in humans with direct effects on glycemic control. Cell Metab. 2018; 27(6): 1201-1211. e3.
[38] Woerle HJ, Albrecht M, Linke R, et al. Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans. Am J Physiol Endocrinol Metab. 2008; 294(1): E103-E109.
[39] Ellingsgaard H, Ehses JA, Hammar EB, et al. Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci U S A. 2008; 105(35): 13163-13168.
[40] Ouchi N, Oshima Y, Ohashi K, et al. Follistatinlike 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem. 2008; 283(47): 32802-32811. 195.
[41] Oshima Y, Ouchi N, Sato K, Izumiya Y, Pimentel DR, Walsh K. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation. 2008; 117(24): 3099-3108.
[42] El-Armouche A, Ouchi N, Tanaka K, et al. Follistatin-like 1 in chronic systolic heart failure: a Fail. 2011; 4(5): 621-627. 197. Tanaka K, Valero-Muñoz M, Wilson RM, et al. Follistatin like 1 regulates hypertrophy in heart failure with preserved ejection fraction. JACC Basic Transl Sci. 2016; 1 (4): 207-221.
[43] Ogura Y, Ouchi N, Ohashi K, et al. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation. 2012; 126(14): 1728-1738.
[44] Seki M, Powers JC, Maruyama S, et al. Acute and chronic increases of circulating FSTL1 normalize energy substrate metabolism in pacing-induced heart failure. Circ Heart Fail. 2018; 11 (1): e004486.
[45] Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab. 2003; 285(2): E433-E437.
[46] Faseb J. 1994; 8(15): 1314-1325.212. Opp MR, Smith EM, Hughes TK Jr. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J Neuroimmunol. 1995; 60(1-2): 165-168. 213.
[47] Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990; 75(1): 40-47.
[48] Wedell-Neergaard AS, Lang Lehrskov L, Christensen RH, et al. Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: a randomized controlled trial. Cell Metab. 2019; 29(4): 844-855. e3.
[49] Christensen RH, Lehrskov LL, Wedell-Neergaard AS, et al. Aerobic exercise induces cardiac fat loss andalters cardiac muscle mass through an interleukin-6 receptor-dependent mechanism: cardiac analysis Downloaded from
[50] Severinsen and Pedersen Myokines in Muscle–Organ Crosstalk Endocrine Reviews, August 2020, 41(4): 594–609 trial in abdominally obese humans. Circulation. 2019; 140(20): 1684-1686.
[51] Christensen RH, Wedell-Neergaard AS, Lehrskov LL, et al. Effect of aerobic and resistance exercise on cardiac adipose tissues: secondary analyses from a randomized clinical trial. JAMA Cardiol. 2019; 4(8): 778-787.
[52] Weigert C, Hoene M, Plomgaard P. Hepatokines-a novel group of exercise factors. Pflugers Arch. 2019; 471 (3): 383-396.
[53] Jespersen NZ, Larsen TJ, Peijs L, et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab. 2013; 17(5): 798-805.
[54] Deshmukh AS, Peijs L, Beaudry JL, et al. Proteomicsbased comparative mapping of the secretomes of human brown and white adipocytes reveals EPDR1 as a novel batokine. Cell Metab. 2019; 30(5): 963-975. e7.
[55] Bente K. Pedersen. Exercise-induced myokines and their role in chronic diseases. Brain, Behavior, and Immunity 25 (2011) 811–816.
Cite This Article
  • APA Style

    Elnaggar, N. K., Elnaggar, M. N. (2025). Body Kines and Organ Crosstalks: A Mini Review. International Journal of Diabetes and Endocrinology, 10(2), 45-53. https://doi.org/10.11648/j.ijde.20251002.13

    Copy | Download

    ACS Style

    Elnaggar, N. K.; Elnaggar, M. N. Body Kines and Organ Crosstalks: A Mini Review. Int. J. Diabetes Endocrinol. 2025, 10(2), 45-53. doi: 10.11648/j.ijde.20251002.13

    Copy | Download

    AMA Style

    Elnaggar NK, Elnaggar MN. Body Kines and Organ Crosstalks: A Mini Review. Int J Diabetes Endocrinol. 2025;10(2):45-53. doi: 10.11648/j.ijde.20251002.13

    Copy | Download

  • @article{10.11648/j.ijde.20251002.13,
      author = {Nabil Kamal Elnaggar and Mohamed Nabil Elnaggar},
      title = {Body Kines and Organ Crosstalks: A Mini Review
    },
      journal = {International Journal of Diabetes and Endocrinology},
      volume = {10},
      number = {2},
      pages = {45-53},
      doi = {10.11648/j.ijde.20251002.13},
      url = {https://doi.org/10.11648/j.ijde.20251002.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20251002.13},
      abstract = {Multiple organs are recently being recognized as having endocrine functions through their release of different hormones and proteins that are responsible for biologically interrelated and inter-connected signaling processes. Diabetes and other chronic diseases are subject to be influenced by these products where modulation or change of their function could take place due to alterations in the signaling processes affected by the secretion of these products In this mini review we tried to take a closer look at how these proteins referred to as “kines” which are considered as the leaders of communication will help the crosstalk between different tissues and it is of utmost important to discover in what way they can do that,. We will review the multiple and complex ways by which kines affect the physiological and pathological processes through reviewing what had been published of the works dealing with the action of different kines and what are the main organs that produce them although a great number of them had not yet been discovered or studied exclusively. The deep identification of their roles in health and diseases will pave the way for the pharmaceutical industry to innovate new drugs that will target their action towards a better organ harmony for the benefits of the patients.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Body Kines and Organ Crosstalks: A Mini Review
    
    AU  - Nabil Kamal Elnaggar
    AU  - Mohamed Nabil Elnaggar
    Y1  - 2025/05/29
    PY  - 2025
    N1  - https://doi.org/10.11648/j.ijde.20251002.13
    DO  - 10.11648/j.ijde.20251002.13
    T2  - International Journal of Diabetes and Endocrinology
    JF  - International Journal of Diabetes and Endocrinology
    JO  - International Journal of Diabetes and Endocrinology
    SP  - 45
    EP  - 53
    PB  - Science Publishing Group
    SN  - 2640-1371
    UR  - https://doi.org/10.11648/j.ijde.20251002.13
    AB  - Multiple organs are recently being recognized as having endocrine functions through their release of different hormones and proteins that are responsible for biologically interrelated and inter-connected signaling processes. Diabetes and other chronic diseases are subject to be influenced by these products where modulation or change of their function could take place due to alterations in the signaling processes affected by the secretion of these products In this mini review we tried to take a closer look at how these proteins referred to as “kines” which are considered as the leaders of communication will help the crosstalk between different tissues and it is of utmost important to discover in what way they can do that,. We will review the multiple and complex ways by which kines affect the physiological and pathological processes through reviewing what had been published of the works dealing with the action of different kines and what are the main organs that produce them although a great number of them had not yet been discovered or studied exclusively. The deep identification of their roles in health and diseases will pave the way for the pharmaceutical industry to innovate new drugs that will target their action towards a better organ harmony for the benefits of the patients.
    
    VL  - 10
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Diabetes, Obesity and Endocrinology Center, Andalusia Hospitals, Alexandria, Egypt

  • Department of Endocrinology, Diabetes and Metabolism, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom

  • Sections